A patient asked my advice for “osteoporosis”.

There is so much to say  about this issue: about prevention , ABOUT MISLEADING DIAGNOSIS, about “what the bones” and really what the body as a whole needs

Mishle: 17:22 [Proverbs] A merry heart is a good medicine; but a broken spirit drieth the bones.

כב  לֵב שָׂמֵחַ, יֵיטִיב גֵּהָה;    וְרוּחַ נְכֵאָה, תְּיַבֶּשׁ-גָּרֶם 

The Hebrew university [hereunder] research is nice but superfluous.

80 years ago [and much longer] any doctor / professor could have told you about such a connection and not just for osteoporosis and as you can see our oldest source Mishle knew about it already

And let we take it with some humor……that even out from MISHLE  a patent [medicine] can be taken…..The Hebrew University’s technology transfer company, Yissum, has applied for a patent for treatment of osteoporosis through antidepressants💲King Salomon [Shlomo] for sure did not need the extra money. And he also gave  a “simple” treatment suggestion from his own book!

Mishlei 15:30 

  שְׁמוּעָה טוֹבָה, תְּדַשֶּׁן-עָצֶם. ……..and a good report maketh the bones fat

Connection Between Depression And Osteoporosis Shown By Hebrew University Researchers

Date:October 31, 2006

Source:The Hebrew University of JerusalemSummary: Depression can cause a loss of bone mass, leading to osteoporosis and fractures, say researchers at the Hebrew University of Jerusalem.Share:     FULL STORY Depression can cause a loss of bone mass, leading to osteoporosis and fractures, say researchers at the Hebrew University of Jerusalem.The researchers say their findings constitute a significant step forward in understanding the interaction between the mind and the skeletal system. Based on their findings, the researchers have already been able to demonstrate the efficacy of anti-depressant drugs in preventing bone mass loss.The findings of the Hebrew University researchers are being published this week in the American journal PNAS (Proceedings of the National Academy of Sciences).Participants in the project were researchers from the university’s Brain and Behavior Laboratory, headed by Prof. Raz Yirmia; from the Bone Laboratory, headed by Prof. Itai Bab; and from the Brain Trauma Laboratory, headed by Prof. Esther Shohami. Also participating were doctoral students Inbal Goshen, Alon Bajayo , Tirza Kreisel, Sharon Feldman and Yosef TamLoss of bone mass is the leading cause of osteoporosis and bone fractures among the aged in general and among post-menopausal women in particular. Several studies indicate that people with major depression generally have a lower bone mass density compared to control samples; however, no direct link between these two conditions has been established.In order to examine the connection between depression and bone mass loss, the researchers used a model involving laboratory mice. Following the induction of a depression-like condition, the mice developed behavioral symptoms mirroring those seen in depressed humans, including a reduction in pleasurable activity and in social interaction.After four weeks in a depressed state, the laboratory animals showed a dramatic bone mass loss, including in the hip bone and vertebrae. This loss was caused by impairment in the bone renewal process, which is essential to maintaining normal bone density. This impairment was caused by a reduction in the number of bone-building cells, which are called osteoblasts.The laboratory tests showed that chronic use of an anti-depressant drug halted not only the depression itself but also the loss of bone density.The researchers were also able to describe the process connecting depression to the skeletal structure. They found that depression sets off a neural system connecting the brain to the internal organs, including the skeleton. This system is called the “sympathetic nervous system.” Its activation causes the secretion within the bone of a chemical compound called noradrenaline, which has a detrimental effect on the bone-building cells. The researchers were able to show that chronic treatment with a drug that blocks noradrenaline in the bone also blocks the detrimental influence of depression on the bone.This research serves as the basis for new, efficient drugs for treatment of osteoporosis, which is the most prevalent degenerative disease in western society. The Hebrew University’s technology transfer company, Yissum, has applied for a patent for treatment of osteoporosis through anti-depressants.”The connection between the brain and the skeleton in general, and the influence of depression on bone mass in particular is a new area of research about which we still know very little,” said Prof. Yirmiya. “The new findings, which we have discovered in the Hebrew University laboratories, point for the first time to depression as an important element in causing bone mass loss and osteoporosis.”Prof. Bab said that “together with other research which we have published in the past year, we have developed a new area of research that we call ‘neuro-psycho-osteology,’ which deals with the connection between the brain, mental states and the skeleton.”The research at the Hebrew University was carried out with funding from the Bikura program of the Israel National Science Foundation.Story Source:Materials provided by The Hebrew University of JerusalemNote: Content may be edited for style and length.